B-type natriuretic peptide and amino terminal proBNP predict one-year mortality in short of breath patients independently of the baseline diagnosis of acute destabilized heart failure.

MLA

Gegenhuber, Alfons, et al. “B-Type Natriuretic Peptide and Amino Terminal ProBNP Predict One-Year Mortality in Short of Breath Patients Independently of the Baseline Diagnosis of Acute Destabilized Heart Failure.” Clinica Chimica Acta; International Journal of Clinical Chemistry, vol. 370, no. 1–2, Aug. 2006, pp. 174–79. EBSCOhost, https://doi.org/10.1016/j.cca.2006.02.010.

APA

Gegenhuber, A., Mueller, T., Dieplinger, B., Poelz, W., Pacher, R., & Haltmayer, M. (2006). B-type natriuretic peptide and amino terminal proBNP predict one-year mortality in short of breath patients independently of the baseline diagnosis of acute destabilized heart failure. Clinica Chimica Acta; International Journal of Clinical Chemistry, 370(1–2), 174–179. https://doi.org/10.1016/j.cca.2006.02.010

Chicago

Gegenhuber, Alfons, Thomas Mueller, Benjamin Dieplinger, Werner Poelz, Richard Pacher, and Meinhard Haltmayer. 2006. “B-Type Natriuretic Peptide and Amino Terminal ProBNP Predict One-Year Mortality in Short of Breath Patients Independently of the Baseline Diagnosis of Acute Destabilized Heart Failure.” Clinica Chimica Acta; International Journal of Clinical Chemistry 370 (1–2): 174–79. doi:10.1016/j.cca.2006.02.010.